IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v372y2025ics0277953625002783.html
   My bibliography  Save this article

Disease frames and their consequences for stigma and medical research funds

Author

Listed:
  • Arseniev-Koehler, Alina
  • Best, Rachel Kahn

Abstract

Illnesses are often understood as criminal acts, as medically treatable conditions, or through metaphors of battles and journeys. Theorists suggest that frames vary across diseases and over time in systematic ways, and that frames have concrete consequences for the distribution of resources. But data limitations have prevented scholars from testing these hypotheses. We combine word embeddings and regression analysis to examine four frames for 104 conditions in news media. Our corpus includes over four million news documents published between 1980 and 2018. First, we study the determinants of disease framing by examining which diseases tend to be medicalized, criminalized, and linked to battle and journey metaphors. We find evidence for systematic links between the demographic characteristics of affected individuals and the extent to which diseases are medicalized or criminalized. Next, we examine disease frames’ consequences for stigma and federal medical research funding. While medical and criminal frames are associated with higher levels of stigma, battle and journey frames are associated with less stigma. And while medical, criminal, and battle frames are associated with more research funding, journey frames are associated with less. Together, our results identify the ways in which the social construction of disease reflects and reinforces social inequality.

Suggested Citation

  • Arseniev-Koehler, Alina & Best, Rachel Kahn, 2025. "Disease frames and their consequences for stigma and medical research funds," Social Science & Medicine, Elsevier, vol. 372(C).
  • Handle: RePEc:eee:socmed:v:372:y:2025:i:c:s0277953625002783
    DOI: 10.1016/j.socscimed.2025.117949
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953625002783
    Download Restriction: Full text for ScienceDirect subscribers only

    File URL: https://libkey.io/10.1016/j.socscimed.2025.117949?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:372:y:2025:i:c:s0277953625002783. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.